Maurizio Recanatini

University of Bologna — Italy

Computer Science · Physical Sciences

54h-index9.5kcitations236works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(66), Cholinesterase and Neurodegenerative Diseases(35), Receptor Mechanisms and Signaling(26), Protein Structure and Dynamics(24), Estrogen and related hormone effects(18)

Publications236 total

Knowledge Graph and Machine Learning Help the Research of Drugs Aimed at Neurological Diseases
2024· 2 citedOpen Access
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
Drug Safety·2024· 11 citedOpen Access
Correction to “Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity”
ACS Medicinal Chemistry Letters·2024Open Access
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
2023· 1 citedOpen Access
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5
Journal of Medicinal Chemistry·2023· 17 citedOpen Access
Network modeling helps to tackle the complexity of drug–disease systems
WIREs Mechanisms of Disease·2023· 4 citedOpen Access
Review: Computational drug discovery under RNA times — R0/PR1
2022Open Access
An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
Artificial Intelligence in the Life Sciences·2022· 1 citedOpen Access
Computational drug discovery under RNA times
QRB Discovery·2022· 18 citedOpen Access
COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19
Scientific Reports·2021· 7 citedOpen Access
Probing the transport of Ni(II) ions through the internal tunnels of the Helicobacter pylori UreDFG multimeric protein complex
Journal of Inorganic Biochemistry·2021· 9 cited
Targeting the JAK/STAT Pathway: A Combined Ligand- and Target-Based Approach
Journal of Chemical Information and Modeling·2021· 11 citedOpen Access
COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19
2021· 1 citedOpen Access
Conduction and Gating Properties of the TRAAK Channel from Molecular Dynamics Simulations with Different Force Fields
Journal of Chemical Information and Modeling·2020· 18 citedOpen Access
Targeting the Protein Tunnels of the Urease Accessory Complex: A Theoretical Investigation
Molecules·2020· 22 citedOpen Access
Drug Research Meets Network Science: Where Are We?
Journal of Medicinal Chemistry·2020· 46 citedOpen Access
Exploring Conformational Dynamics of the Extracellular <i>Venus flytrap</i> Domain of the GABA<sub>B</sub> Receptor: A Path-Metadynamics Study
Journal of Chemical Information and Modeling·2020· 12 citedOpen Access
Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning
European Journal of Medicinal Chemistry·2019· 19 citedOpen Access
An Integrated Markov State Model and Path Metadynamics Approach To Characterize Drug Binding Processes
Journal of Chemical Theory and Computation·2019· 66 cited
Multi-Target Dopamine D3 Receptor Modulators: Actionable Knowledge for Drug Design from Molecular Dynamics and Machine Learning
2019Open Access
page 1 of 12Next →

Frequent Co-authors

Andrea Cavalli(36), Vincenza Andrisano(15), Angela Rampa(14), Alessandra Bisi(12), Silvia Gobbi(12), Federica Belluti(12), Manuela Bartolini(12), Lorna Piazzi(11), Piero Valenti(10), Matteo Masetti(8), María Laura Bolognesi(6), Carlo Melchiorre(6), Michela Rosini(5), Fabrizio De Ponti(5), Marinella Roberti(5), Vanni Cavrini(5), Rolf W. Hartmann(5), Vincenzo Tumiatti(4), Elisabetta Poluzzi(4), Anna Minarini(3)